Page 144 - IJB-7-4
P. 144

3D-Printed  Anti-Tumor Scaffolds
                         A
























                         B                                   C
















           Figure 5. Evaluation of anticancer effect in vitro. (A) Live/Dead fluoresce staining of 4T1 cells on polylactic acid/methotrexate (PLA/MTX).
           The cells were cultured in DMEM for 12 h, 24 h, 72 h, and 120 h. Viable cells are stained green while dead cells red. (B) In vitro proliferation
           of 4T1 cells after culturing in the PLA/MTX (0.5%, 1.5%, and 2.5%) scaffolds and the tissue culture plates substrate (as control) for 1, 3,
           and 5 days. (C) Inhibition rate at different MTX concentrations.

           that of injection group. The anti-tumor effects of 2.5%   Table 1. Tumor weight and tumor growth inhibition value (TGI)
           PLA/MTX scaffold with high concentration of drug were   of each group
           relatively  better  than  that  of  0.5%  PLA/MTX  scaffold   Group      Tumor weight (g)     TGI
           with low concentration of drug (Figure 6D). The mean   2.5% PLA/MTX       0.1557±0.024       89.26%
           tumor volume of the control group was above 1300 mm ,   0.5% PLA/MTX      0.33524±0.042      76.88%
                                                         3
           which was much larger than tumor volume in the 0.5%   Injection           0.3763±0.018       74.04%
           PLA/MTX and 2.5% PLA/MTX groups (<400 mm ).         Control                 1.45±0.3           -
                                                      3
               As shown in Table 1, PLA/MTX scaffold groups    TGI, tumor growth inhibition value.
           were more effective than the MTX injection in controlling
           tumor growth. The anti-tumor effect of the 2.5% PLA/    The  hematoxylin  and  eosin  (H  and  E)  staining
           MTX  scaffold  group  was  also  significantly  different
           from that of the 0.5% PLA/MTX group (P < 0.05). The   results  in  Figure  7  showed  that  some  area  of  tumor
           main reason is that the injected drug is eliminated by   necrosis  appeared  in  the  sections  of  0.5%  PLA/MTX
           renal  metabolism  in  a  short  time,  resulting  in  a  short   group, 2.5% PLA/MTX group, and injection group. The
           plasma  half-life  (5-8  h)  and  low  drug  concentration   nuclei  of  cancer  cells  enlarged,  produced  cavities  and
           in  target  tissues.  The  tumor  growth  inhibition  value   the cells showed apoptosis and necrosis. Eventually, the
           (TGI) of high concentration group could reach 89.26%,   nucleus  breaks,  creating  a  “ghost”  area.  There  was  no
           which was higher than 74.04% in injection group. The   obvious tumor necrosis in the control group. No obvious
           results  indicated  that  PLA/MTX  scaffold  had  a  better   metastasis  and  inflammatory  were  found  in  the  0.5%
           therapeutic  effect  than  the  intraperitoneal  injection  of   PLA/MTX group and 2.5% PLA/MTX group, while the
           drugs.                                              control group showed metastases. The H and E staining

           140                         International Journal of Bioprinting (2021)–Volume 7, Issue 4
   139   140   141   142   143   144   145   146   147   148   149